- Correction: Cardiorenal effectiveness of empagliflozin vs. glucagon-like peptide-1 receptor agonists: final-year results … Cardiovascular Diabetology
- Arch Biopartners Clinical Team Publishes Data from Phase II Trial for LSALT Peptide Targeting Organ Inflammation Marketscreener.com
- De novo antioxidant peptide design via machine learning and DFT studies | Scientific Reports Nature.com
- Arch Biopartners Clinical Team Publishes Data from Phase II Trial for LSALT Peptide Targeting Organ Inflammation in … Yahoo Finance
- 18 Best Lash Growth Serums of 2024, According to Reviews Vogue
- This Peptide Cream 'Firms, Freezes and Plumps' for Youthful-Looking Skin NewBeauty Magazine
- Immunopeptidomics-based identification of naturally presented non-canonical circRNA-derived peptides Nature.com
- University of Calgary Joins the Phase II Trial of LSALT Peptide Targeting Cardiac Surgery Associated-Acute Kidney Injury Yahoo Finance
- Peptide Synthesis Market Trends and Global Forecasts, 2035 PR Newswire
- Physics – Molecular Lawnmower Drives Itself Physics